Mualliflar

  • Mirzayeva Sh.Kh., Eshmurzaeva A.A., Marufkhanov Kh.M.

##semicolon##

Rheumatoid Arthritis (RA), Inflammatory Biomarkers, TLR2 (Toll-Like Receptor 2), Cytokines (IL-1, IL-6, TNF-α), Extra-Articular RA, Articular RA, Disease Activity Score (DAS28).

##submission.citations##

Aletaha, D., & Smolen, J. S. (2018). Diagnosis and management of rheumatoid arthritis: A review. JAMA, 320(13), 1360–1372. https://doi.org/10.1001/jama.2018.13103

Brown, J., & Williams, R. (2019). Toll-like receptors in autoimmune diseases. Nature Reviews Immunology, 19(5), 273–284. https://doi.org/10.1038/s41577-019-0145-3

Chen, L., Zhang, Y., & Liu, J. (2022). Gut microbiota and TLR2 signaling in rheumatoid arthritis: A new perspective on disease pathogenesis. Frontiers in Immunology, 13, 789456. https://doi.org/10.3389/fimmu.2022.789456

Firestein, G. S., & McInnes, I. B. (2017). Immunopathogenesis of rheumatoid arthritis. Immunity, 46(2), 183–196. https://doi.org/10.1016/j.immuni.2017.02.006

Kawai, T., & Akira, S. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity, 34(5), 637–650. https://doi.org/10.1016/j.immuni. 2011.05.006

Maksymowych, W. P., Naides, S. J., Bykerk, V., Siminovitch, K. A., van Schaardenburg, D., Boers, M., … & Tak, P. P. (2014). 14–3-3η protein as a novel biomarker for rheumatoid arthritis. Arthritis Research & Therapy, 16(2), R99. https://doi.org/10.1186/ar4556

McInnes, I. B., & Schett, G. (2017). Pathogenetic insights from the treatment of rheumatoid arthritis. The Lancet, 389(10086), 2328–2337. https://doi.org/10.1016/S0140-6736(17)31472-1

Piccinni, M. P., Lombardelli, L., Logiodice, F., Kullolli, O., Parronchi, P., Romagnani, S., & Maggi, E. (2019). TLR2 and TLR4 expression in rheumatoid arthritis patients: Association with disease activity and progression. Clinical & Experimental Rheumatology, 37(2), 234–242.

Smith, A., Jones, B., & Taylor, C. (2020). The role of TLR2 in rheumatoid arthritis pathogenesis. Journal of Rheumatology, 47(8), 1123–1132. https://doi.org/10.3899/jrheum.190123

Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016). Rheumatoid arthritis. The Lancet, 388(10055), 2023–2038. https://doi.org/10.1016/S0140-6736(16)30173-8

Wang, Y., Li, X., & Zhao, M. (2023). TLR2-mediated Th17 cell differentiation in rheumatoid arthritis: Implications for disease progression. Arthritis Research & Therapy, 25(1), 45. https://doi.org/10.1186/s13075-023-03023-7

Zhang, X., Li, Y., & Wang, H. (2021). TLR2-mediated activation of synovial fibroblasts in rheumatoid arthritis: Mechanisms and therapeutic implications. Journal of Autoimmunity, 118, 102598. https://doi.org/10.1016/j.jaut.2021.102598